IBRX
Immunitybio Inc
Price:  
7.10 
USD
Volume:  
8,789,621.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IBRX Stock Forecast & Price Target

IBRX Stock Price Forecast

The average stock forecast for Immunitybio Inc (IBRX) in the next 12 months is 12.75 USD. This price target corresponds to an upside of 79.58%. The range of stock forecasts for IBRX is 11.11 - 15.75 USD. Based on the ratings of 10 analysts, the consensus recommendation for IBRX is BUY.
Target Low Average Median High
Price (USD) 11.11 12.75 12.24 15.75
Upside 56.48% 79.58% 72.39% 121.83%

Recommendation Trends

The latest consensus rating for IBRX is "BUY". This is the average recommendation of 10 analysts: 0 strong sell, 0 sell, 1 hold, 5 buy, 4 strong buy. In the previous period, 11 analysts also majorly recommmended "BUY" for IBRX.

IBRX Financial Stock Forecast

Revenue This Year
226.78M
100.18%
from 113.29M
Revenue Next Year
461.07M
103.31%
from 226.78M
EPS This Year
-0.86
155.88%
from -0.34
EPS Next Year
-0.16
-81.57%
from -0.86